. . . . . . . "[In luciferase assay experiments using the 5-flanking region of the human NQO1 gene promoter, we observe that ER? ligand-binding domain (LBD) is required for estrogen inhibition of NQO1 promoter activity in estrogen-dependent breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:12:30+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .